[Endocrinology and nuclear medicine aspects of the treatment of thyroid tumours].
Thyroid tumours belong among the most frequent malignant tumours in endocrinology. The rate of incidence of new carcinomas has increased dramatically in recent years; the rate of thyroid tumour incidence, in particular of its less advanced papillary forms, sextupled in the Czech Republic in the previous decade. The article brings an overview of the factors involved in the development of thyroid tumours, and the classification and clinical assessment of their different types. Recombinant human TSH has started to be used in the Czech Republic as part of preparation of patients for radioiodine treatment. Also discussed is the relevance of tumour markers for the prognosis of the disease in the context of life-long monitoring of patients with thyroid carcinoma.
Vicek
P
P
Klinika nukleární medicíny a endokrinologie 2. lékarské fakulty UK a FN Motol, Praha. petr.vlcek@fnmotol.cz
D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use; D013964:Thyroid Neoplasms / Q000145:classification / Q000175:diagnosis / Q000532:radiotherapy / Q000628:therapy*; D013972:Thyrotropin / Q000627:therapeutic use*
D007457:Iodine Radioisotopes; D011994:Recombinant Proteins; D013972:Thyrotropin